Tal Birnberg

Tal Birnberg has a diverse work experience in the field of clinical pharmacology and personalized medicine. They are currently serving as the Head of Clinical Pharmacology at Clexio Biosciences since 2022. Prior to this, Tal worked as the Clinical Pharmacology and Personalized Medicine Manager at Neuroderm from 2017 to 2022. They also held positions at Teva Pharmaceutical Industries Ltd., starting as an Experimental Medicine Leader from 2011 to 2013 and later becoming a Personalized Medicine and Pharmacogenomics expert from 2013 to 2017. Before joining Teva Pharmaceutical Industries, Tal was a Research Coordinator at Teva Pharmaceuticals in 2010, focusing on MS & Autoimmune research.

Tal Birnberg holds a PhD in Immunology from the Weizmann Institute of Science. In addition, Tal Birnberg has obtained a certification from Jolt.io in 2020.